TOLToleranzia ABTOL info
$0.05info-8.03%24h
Global rank
Market cap$9.73M
Change 7d14.35%
YTD Performance28.21%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Toleranzia AB (TOL) Stock Overview

    Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also develops TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. Toleranzia AB was incorporated in 2011 and is headquartered in Gothenburg, Sweden.

    TOL Stock Information

    Symbol
    TOL
    Address
    Erik Dahlbergsgatan 11AGothenburg, 411 26Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.toleranzia.com
    Country
    πŸ‡ΈπŸ‡ͺ Sweden
    Phone Number
    46 7 63 19 98 98

    Toleranzia AB (TOL) Price Chart

    -
    Value:-

    Toleranzia AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.04939202902455233
    N/A
    Market Cap
    $9.73M
    N/A
    Shares Outstanding
    197.07M
    N/A
    Employees
    11.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org